Suppr超能文献

[药物诱导的胶原病大鼠的视黄醇水平、超氧化物歧化酶活性及脂质过氧化程度]

[Retinol level, superoxide dismutase activity and the degree of lipid peroxidation in rats with drug-induced collagenosis].

作者信息

Magner-Wróbel K, Drózdz M

机构信息

Katedry i Zakładu Biochemii i Chemii Sl. AM w Katowicach.

出版信息

Przegl Lek. 1990;47(10):698-701.

PMID:2089447
Abstract

The retinol effect on symptoms of late toxicity of hydralazine in rats of Wistar strain during induction of the collagenosis-like syndrome has been studied. Studies have been performed during 360 days, and examination were done in three months lasting intervals. Animals were divided into 3 groups: the first was treated with hydralazine, the second with hydralazine plus retinol, and the third corresponded to the control group. It has been stated that the long-term administration of hydralazine caused the lowering of the retinol level in the serum and liver progressing according to the time of the drug use. The mean lowering of the retinol concentration for animals of the first group was 20.7% in the serum and 24.7% in the liver. Analogous results in the second group were 12.1% and 14.7%, respectively. Simultaneously activity of superoxide dismutase measured in the kidney and heart muscle homogenates was significantly lowered in animals receiving hydralazine solely. Retinol administered together with hydralazine caused an increase in the enzyme activity (about 30%) when compare with animals treated only with hydralazine. The lowering of the retinol level and of dismutase activity caused beneficial conditions for increased lipid peroxidation measured by an increase in the malonic aldehyde concentration. The concentration of malonic dialdehyde in kidneys of rats treated solely with hydralazine increased about twofold, and in the heart muscle about 3.5-fold. The supplementation of the diet with retinol in rats treated solely with hydralazine partially limited effects of enhanced free radical activity reflected in increased lipid peroxidation.

摘要

研究了视黄醇对诱导胶原病样综合征期间Wistar品系大鼠肼屈嗪晚期毒性症状的影响。研究持续了360天,每隔三个月进行一次检查。动物分为3组:第一组用肼屈嗪治疗,第二组用肼屈嗪加视黄醇治疗,第三组为对照组。结果表明,长期服用肼屈嗪会导致血清和肝脏中视黄醇水平随用药时间的延长而降低。第一组动物血清中视黄醇浓度平均降低20.7%,肝脏中降低24.7%。第二组的类似结果分别为12.1%和14.7%。同时,仅接受肼屈嗪治疗的动物肾脏和心肌匀浆中超氧化物歧化酶的活性显著降低。与仅用肼屈嗪治疗的动物相比,视黄醇与肼屈嗪一起给药可使酶活性增加(约30%)。视黄醇水平和歧化酶活性的降低为通过丙二醛浓度增加来衡量的脂质过氧化增加创造了有利条件。仅用肼屈嗪治疗的大鼠肾脏中丙二醛的浓度增加了约两倍,心肌中增加了约3.5倍。在仅用肼屈嗪治疗的大鼠饮食中补充视黄醇,部分限制了脂质过氧化增加所反映的自由基活性增强的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验